PERFUSION MEDICAL LLC

Herndon, VA · Medtech · Private

Intravenous solution for treating septic and hemorrhagic shock

perfusionmedical.com →
Grants
$3.6M
5 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
$5.2M
4 awards · Defense
#121 of 4531 in medtech
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grant· 1 of 2 same dayDepartment of Health and Human Services · Phase I · Polymer use in Preservation of Tissue Perfusion to Address Sepsis$256,492
Federal grant· 2 of 2 same dayDepartment of Health and Human Services · Phase I · Polymer use in Preservation of Tissue Perfusion to Address Sepsis$256,492
Federal grant· 1 of 2 same dayDepartment of Defense · Phase I · The Mayo Clinic and Perfusion Medical: PEG-20k/8k - A Patented Intravenous Solution to Treat Septic Shock$74,948
Federal grant· 2 of 2 same dayDepartment of Defense · Phase I · The Mayo Clinic and Perfusion Medical: PEG-20k/8k - A Patented Intravenous Solution to Treat Hemorrhagic Shock$74,948
Federal grantDepartment of Defense · Phase II · IND-enabling Studies of PM-208: A Novel Pre-hospital Anti-Shock Therapeutic$2,986,773
Federal contractDepartment of Defense · Research And Development Of Optimal Dosing And Formulation Of PM-208 (PEG-20K/8K) For Af Field Use$1,799,322
Federal contractDepartment of Defense · Polyethylene GLYCOL-20K/8K (PEG-20K/8K): A Patented Intravenous Solution In Uncontrolled Hemorrhage$109,917
Federal contractDepartment of Defense · Human Clinical Trial For Safety Of PM-208 Anti-shock Drug$1,799,970
Federal contractDepartment of Defense · Ind-enabling Studies Of PM-208: A Novel Pre-hospital Anti-shock Therapeutic$1,499,773
Federal grant · SBIR/STTRFederal contract · USAspending

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
118MOTION CONTROL, INC$5.4M—
119VIA THERAPEUTICS, LLC$5.4M—
120KERICURE INC.$5.3M$310K
121PERFUSION MEDICAL LLC$5.2M—
122Gate Scientific, Inc.$5.1M—
123AA PLASMA LLC$5.0M—
124DAXOR CORPORATION$4.9M—

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.